HSD17B13 and metabolic dysfunction-associated steatotic liver disease: The results showed that the higher expression of HSD17B13 was, identically, mainly in the PHs of mouse NAFLD models that were induced by HFD, BDL, CCl4, or MCD, showing with the co-localization of HSD17B13 with PHs (albumin, ALB) (Figure 2C).